Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study

Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia. Herein, we sought to compare levels of amino acids and derivatives between subjects with...

Full description

Saved in:
Bibliographic Details
Published inAmino acids Vol. 50; no. 8; pp. 1013 - 1023
Main Authors Cao, Bing, Wang, Dongfang, Brietzke, Elisa, McIntyre, Roger S., Pan, Zihang, Cha, Danielle, Rosenblat, Joshua D., Zuckerman, Hannah, Liu, Yaqiong, Xie, Qing, Wang, Jingyu
Format Journal Article
LanguageEnglish
Published Vienna Springer Vienna 01.08.2018
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0939-4451
1438-2199
1438-2199
DOI10.1007/s00726-018-2579-6

Cover

Loading…
Abstract Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia. Herein, we sought to compare levels of amino acids and derivatives between subjects with schizophrenia and healthy controls (HC). Two hundred and eight subjects with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV)-defined schizophrenia and 175 age- and sex-matched HC were enrolled. The levels of twenty-five amino acids and seven related derivatives were measured in plasma samples using hydrophilic interaction liquid chromatography (HILIC) liquid chromatography–tandem mass spectrometry (LC–MS). After controlling for age, sex and body mass index (BMI), four amino acids and derivatives (i.e., cysteine, GABA, glutamine and sarcosine) were observed to be higher in the schizophrenia group when compared with HC; seven amino acids and derivatives were lower in the schizophrenia group (i.e., arginine, l -ornithine, threonine, taurine, tryptophan, methylcysteine, and kynurenine). Statistically significant differences in plasma amino-acid profiles between subjects with first-episode vs. recurrent schizophrenia for aspartate and glutamine were also demonstrated using generalized linear models controlling for age, sex, and BMI. The differences in amino acids and derivatives among individuals with schizophrenia when compared to HC may represent underlying pathophysiology, including but not limited to dysfunctional proteinogenic processes, alterations in excitatory and inhibitory neurotransmission, changes in ammonia metabolism and the urea cycle. Taken together, amino-acid profiling may provide a novel stratification approach among individuals with schizophrenia.
AbstractList Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia. Herein, we sought to compare levels of amino acids and derivatives between subjects with schizophrenia and healthy controls (HC). Two hundred and eight subjects with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV)-defined schizophrenia and 175 age- and sex-matched HC were enrolled. The levels of twenty-five amino acids and seven related derivatives were measured in plasma samples using hydrophilic interaction liquid chromatography (HILIC) liquid chromatography-tandem mass spectrometry (LC-MS). After controlling for age, sex and body mass index (BMI), four amino acids and derivatives (i.e., cysteine, GABA, glutamine and sarcosine) were observed to be higher in the schizophrenia group when compared with HC; seven amino acids and derivatives were lower in the schizophrenia group (i.e., arginine, L-ornithine, threonine, taurine, tryptophan, methylcysteine, and kynurenine). Statistically significant differences in plasma amino-acid profiles between subjects with first-episode vs. recurrent schizophrenia for aspartate and glutamine were also demonstrated using generalized linear models controlling for age, sex, and BMI. The differences in amino acids and derivatives among individuals with schizophrenia when compared to HC may represent underlying pathophysiology, including but not limited to dysfunctional proteinogenic processes, alterations in excitatory and inhibitory neurotransmission, changes in ammonia metabolism and the urea cycle. Taken together, amino-acid profiling may provide a novel stratification approach among individuals with schizophrenia.
Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia. Herein, we sought to compare levels of amino acids and derivatives between subjects with schizophrenia and healthy controls (HC). Two hundred and eight subjects with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV)-defined schizophrenia and 175 age- and sex-matched HC were enrolled. The levels of twenty-five amino acids and seven related derivatives were measured in plasma samples using hydrophilic interaction liquid chromatography (HILIC) liquid chromatography–tandem mass spectrometry (LC–MS). After controlling for age, sex and body mass index (BMI), four amino acids and derivatives (i.e., cysteine, GABA, glutamine and sarcosine) were observed to be higher in the schizophrenia group when compared with HC; seven amino acids and derivatives were lower in the schizophrenia group (i.e., arginine, l -ornithine, threonine, taurine, tryptophan, methylcysteine, and kynurenine). Statistically significant differences in plasma amino-acid profiles between subjects with first-episode vs. recurrent schizophrenia for aspartate and glutamine were also demonstrated using generalized linear models controlling for age, sex, and BMI. The differences in amino acids and derivatives among individuals with schizophrenia when compared to HC may represent underlying pathophysiology, including but not limited to dysfunctional proteinogenic processes, alterations in excitatory and inhibitory neurotransmission, changes in ammonia metabolism and the urea cycle. Taken together, amino-acid profiling may provide a novel stratification approach among individuals with schizophrenia.
Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia. Herein, we sought to compare levels of amino acids and derivatives between subjects with schizophrenia and healthy controls (HC). Two hundred and eight subjects with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV)-defined schizophrenia and 175 age- and sex-matched HC were enrolled. The levels of twenty-five amino acids and seven related derivatives were measured in plasma samples using hydrophilic interaction liquid chromatography (HILIC) liquid chromatography-tandem mass spectrometry (LC-MS). After controlling for age, sex and body mass index (BMI), four amino acids and derivatives (i.e., cysteine, GABA, glutamine and sarcosine) were observed to be higher in the schizophrenia group when compared with HC; seven amino acids and derivatives were lower in the schizophrenia group (i.e., arginine, L-ornithine, threonine, taurine, tryptophan, methylcysteine, and kynurenine). Statistically significant differences in plasma amino-acid profiles between subjects with first-episode vs. recurrent schizophrenia for aspartate and glutamine were also demonstrated using generalized linear models controlling for age, sex, and BMI. The differences in amino acids and derivatives among individuals with schizophrenia when compared to HC may represent underlying pathophysiology, including but not limited to dysfunctional proteinogenic processes, alterations in excitatory and inhibitory neurotransmission, changes in ammonia metabolism and the urea cycle. Taken together, amino-acid profiling may provide a novel stratification approach among individuals with schizophrenia.Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia. Herein, we sought to compare levels of amino acids and derivatives between subjects with schizophrenia and healthy controls (HC). Two hundred and eight subjects with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV)-defined schizophrenia and 175 age- and sex-matched HC were enrolled. The levels of twenty-five amino acids and seven related derivatives were measured in plasma samples using hydrophilic interaction liquid chromatography (HILIC) liquid chromatography-tandem mass spectrometry (LC-MS). After controlling for age, sex and body mass index (BMI), four amino acids and derivatives (i.e., cysteine, GABA, glutamine and sarcosine) were observed to be higher in the schizophrenia group when compared with HC; seven amino acids and derivatives were lower in the schizophrenia group (i.e., arginine, L-ornithine, threonine, taurine, tryptophan, methylcysteine, and kynurenine). Statistically significant differences in plasma amino-acid profiles between subjects with first-episode vs. recurrent schizophrenia for aspartate and glutamine were also demonstrated using generalized linear models controlling for age, sex, and BMI. The differences in amino acids and derivatives among individuals with schizophrenia when compared to HC may represent underlying pathophysiology, including but not limited to dysfunctional proteinogenic processes, alterations in excitatory and inhibitory neurotransmission, changes in ammonia metabolism and the urea cycle. Taken together, amino-acid profiling may provide a novel stratification approach among individuals with schizophrenia.
Author Wang, Dongfang
Wang, Jingyu
Liu, Yaqiong
Cao, Bing
Zuckerman, Hannah
McIntyre, Roger S.
Brietzke, Elisa
Pan, Zihang
Cha, Danielle
Rosenblat, Joshua D.
Xie, Qing
Author_xml – sequence: 1
  givenname: Bing
  surname: Cao
  fullname: Cao, Bing
  organization: Department of Laboratorial Science and Technology, School of Public Health, Peking University
– sequence: 2
  givenname: Dongfang
  surname: Wang
  fullname: Wang, Dongfang
  organization: Department of Laboratorial Science and Technology, School of Public Health, Peking University
– sequence: 3
  givenname: Elisa
  surname: Brietzke
  fullname: Brietzke, Elisa
  organization: Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Department of Psychiatry, Federal University of São Paulo
– sequence: 4
  givenname: Roger S.
  surname: McIntyre
  fullname: McIntyre, Roger S.
  organization: Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Brain and Cognition Discovery Foundation
– sequence: 5
  givenname: Zihang
  surname: Pan
  fullname: Pan, Zihang
  organization: Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network
– sequence: 6
  givenname: Danielle
  surname: Cha
  fullname: Cha, Danielle
  organization: Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Faculty of Medicine, School of Medicine, University of Queensland
– sequence: 7
  givenname: Joshua D.
  surname: Rosenblat
  fullname: Rosenblat, Joshua D.
  organization: Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network
– sequence: 8
  givenname: Hannah
  surname: Zuckerman
  fullname: Zuckerman, Hannah
  organization: Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network
– sequence: 9
  givenname: Yaqiong
  surname: Liu
  fullname: Liu, Yaqiong
  organization: Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Peking University Medical and Health Analysis Center, Peking University
– sequence: 10
  givenname: Qing
  surname: Xie
  fullname: Xie, Qing
  organization: Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Peking University Medical and Health Analysis Center, Peking University
– sequence: 11
  givenname: Jingyu
  surname: Wang
  fullname: Wang, Jingyu
  email: wjy@bjmu.edu.cn
  organization: Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Peking University Medical and Health Analysis Center, Peking University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29796929$$D View this record in MEDLINE/PubMed
BookMark eNqFkctqVDEch4O02Gn1AdzIATdujs0_l5OJOxm8QaEbXYecXGZSziRjkmNpV76Db-iTmGFahELrJhfyfT-S_E7RUUzRIfQK8DvAWJyXNpChx7DsCReyH56hBTDadiDlEVpgSWXPGIcTdFrKFcZAljA8RydECjlIIhfIrzY6a1NdDrchrju9DTH12gTbjSGVsI66ztmVdpDiutQuRBt-BjvrqXTXoW66YjbhNu022cWg33e6M7q4P79-mxRrTlNX6mxvXqBj3wz38m4-Q98_ffy2-tJfXH7-uvpw0RtGae0tBWutpwx7A1R7IpacMTk6j2Ec2xqPgzREajEI6-1oBBg7ejNSzpl3QM_Q20PuLqcfsytVbUMxbpp0dGkuigAGSpaU8v-jmHEiOBaioW8eoFdpzrE9RFGQXFApKHuKallEMkkFadTrO2oet86qXQ5bnW_UfSUNEAfA5FRKdl6ZUHUN--_UYVKA1b58dShftfLVvnw1NBMemPfhTznk4JTGxrXL_y79uPQXJa7CRA
CitedBy_id crossref_primary_10_1021_acs_analchem_4c06133
crossref_primary_10_1186_s12888_024_05765_5
crossref_primary_10_1016_j_aca_2020_09_054
crossref_primary_10_3389_fimmu_2022_812293
crossref_primary_10_1016_j_bionps_2021_100045
crossref_primary_10_3390_pharmaceutics15071857
crossref_primary_10_1038_s41380_022_01552_4
crossref_primary_10_1016_j_psychres_2018_11_064
crossref_primary_10_3389_fimmu_2019_02971
crossref_primary_10_1038_s41398_024_03157_7
crossref_primary_10_1016_j_schres_2020_09_007
crossref_primary_10_1016_j_jad_2022_12_004
crossref_primary_10_1016_j_psychres_2021_113880
crossref_primary_10_14336_AD_2023_0902
crossref_primary_10_1038_s41598_020_78559_w
crossref_primary_10_1002_anie_202101007
crossref_primary_10_1038_s41380_020_0826_1
crossref_primary_10_1002_npr2_12223
crossref_primary_10_1080_15622975_2020_1769188
crossref_primary_10_1021_acs_jproteome_1c00504
crossref_primary_10_1080_15622975_2023_2271965
crossref_primary_10_1016_j_neures_2021_12_006
crossref_primary_10_1038_s41380_020_00951_9
crossref_primary_10_1093_schbul_sbad026
crossref_primary_10_1093_schbul_sbad047
crossref_primary_10_1515_abm_2020_0009
crossref_primary_10_3390_molecules24091658
crossref_primary_10_1136_bcr_2024_259623
crossref_primary_10_1016_j_cca_2023_117650
crossref_primary_10_7717_peerj_9574
crossref_primary_10_1016_j_neubiorev_2021_01_018
crossref_primary_10_1016_j_schres_2020_11_016
crossref_primary_10_20538_1682_0363_2019_4_197_208
crossref_primary_10_1016_j_ejpsy_2023_100229
crossref_primary_10_1016_j_jtemb_2018_10_009
crossref_primary_10_1002_ange_202101007
Cites_doi 10.4155/bio.12.100
10.7717/peerj.3451
10.1093/schbul/sbp006
10.1016/j.jpsychires.2014.03.021
10.1371/journal.pone.0150524
10.1186/1471-2202-9-41
10.1254/fpj.127.279
10.4239/wjd.v8.i8.390
10.4155/bio.12.46
10.1155/2017/7382752
10.1038/jcbfm.2010.193
10.1016/j.euroneuro.2008.04.002
10.1038/tp.2014.19
10.1186/1750-1172-9-65
10.1016/j.pnpbp.2010.07.006
10.1126/science.aaf9794
10.1016/j.neuroimage.2017.11.026
10.1016/j.neuint.2014.03.001
10.1097/FBP.0b013e3283347091
10.5483/BMBRep.2010.43.9.593
10.1007/BF00431959
10.1016/j.schres.2005.05.019
10.1021/ac201195d
10.1016/j.talanta.2016.04.049
10.1155/2015/506872
10.1016/j.dsx.2017.11.006
10.1016/j.pnpbp.2007.06.009
10.1159/000455234
10.1016/j.psychres.2013.09.014
10.1016/j.eurpsy.2017.04.004
10.1021/pr200629p
10.1186/1745-6150-8-5
10.1159/000081113
10.1186/gm233
10.3390/metabo2030496
10.1017/S000711450769936X
10.1016/j.brainresbull.2008.12.014
10.1038/mp.2009.33
10.1016/j.mehy.2013.03.013
10.4137/IJTR.S16800
10.1016/0165-1781(90)90136-S
10.1017/neu.2015.22
10.1016/j.biopsych.2016.04.007
10.1136/adc.2003.048389
10.1007/s11306-012-0482-9
10.1111/j.1460-9568.2012.08156.x
10.1016/j.bbagen.2012.05.012
10.1002/jssc.200700644
10.1016/j.neuropharm.2013.08.038
10.1002/jssc.200900798
10.1038/tp.2012.76
10.1053/jhep.2002.36497
10.1016/j.nicl.2014.03.007
10.1007/s00726-010-0670-8
10.1016/j.aquatox.2013.01.003
10.1016/j.psychres.2010.07.013
10.1038/sj.mp.4001511
10.33588/rn.5407.2011454
ContentType Journal Article
Copyright Springer-Verlag GmbH Austria, part of Springer Nature 2018
Amino Acids is a copyright of Springer, (2018). All Rights Reserved.
Copyright Springer Nature B.V. Aug 2018
Copyright_xml – notice: Springer-Verlag GmbH Austria, part of Springer Nature 2018
– notice: Amino Acids is a copyright of Springer, (2018). All Rights Reserved.
– notice: Copyright Springer Nature B.V. Aug 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
D1I
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB.
LK8
M0S
M1P
M7P
PDBOC
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
DOI 10.1007/s00726-018-2579-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
Materials Science Database
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Materials Science Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE

AGRICOLA
MEDLINE - Academic
ProQuest Central Student
ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1438-2199
EndPage 1023
ExternalDocumentID 29796929
10_1007_s00726_018_2579_6
Genre Journal Article
GrantInformation_xml – fundername: Health Science Center, Peking University
  grantid: BMU20140435
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1SB
2.D
203
23M
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67N
67Z
6NX
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAHBH
AAHNG
AAIAL
AAJKR
AAJSJ
AAKKN
AANXM
AANZL
AARHV
AARTL
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABEEZ
ABFTV
ABHLI
ABHQN
ABJCF
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMOR
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACACY
ACBXY
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACSNA
ACULB
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFGXO
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BPHCQ
BVXVI
C24
C6C
CAG
CCPQU
COF
CS3
CSCUP
D1I
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GROUPED_DOAJ
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KB.
KDC
KOV
KOW
KPH
LAS
LK8
LLZTM
M1P
M4Y
M7P
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PDBOC
PF0
PQQKQ
PROAC
PSQYO
PT5
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
W4F
WJK
WK6
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z81
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8U
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~EX
AASML
AAYXX
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFHIU
AGQPQ
AHPBZ
AHWEU
AIXLP
AYFIA
CITATION
PHGZM
PHGZT
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PQEST
PQUKI
PRINS
7X8
7S9
L.6
ID FETCH-LOGICAL-c433t-d31dddf340fc13af2785449bef01bb8540b69c29a767dfdbc71cdbfcb3554fe13
IEDL.DBID 7X7
ISSN 0939-4451
1438-2199
IngestDate Fri Jul 11 08:03:41 EDT 2025
Fri Jul 11 15:32:37 EDT 2025
Fri Jul 25 10:58:41 EDT 2025
Fri Jul 25 11:10:40 EDT 2025
Wed Feb 19 02:35:13 EST 2025
Thu Jul 10 07:27:50 EDT 2025
Thu Apr 24 22:49:11 EDT 2025
Fri Feb 21 02:37:24 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Schizophrenia
Metabolomics
Amino acid
Liquid chromatography–mass spectrometry
Targeting profiles
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c433t-d31dddf340fc13af2785449bef01bb8540b69c29a767dfdbc71cdbfcb3554fe13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 29796929
PQID 2042949372
PQPubID 1456339
PageCount 11
ParticipantIDs proquest_miscellaneous_2101328335
proquest_miscellaneous_2045275077
proquest_journals_3195739734
proquest_journals_2042949372
pubmed_primary_29796929
crossref_citationtrail_10_1007_s00726_018_2579_6
crossref_primary_10_1007_s00726_018_2579_6
springer_journals_10_1007_s00726_018_2579_6
PublicationCentury 2000
PublicationDate 20180800
2018-8-00
2018-Aug
20180801
PublicationDateYYYYMMDD 2018-08-01
PublicationDate_xml – month: 8
  year: 2018
  text: 20180800
PublicationDecade 2010
PublicationPlace Vienna
PublicationPlace_xml – name: Vienna
– name: Austria
PublicationSubtitle The Forum for Amino Acid, Peptide and Protein Research
PublicationTitle Amino acids
PublicationTitleAbbrev Amino Acids
PublicationTitleAlternate Amino Acids
PublicationYear 2018
Publisher Springer Vienna
Springer Nature B.V
Publisher_xml – name: Springer Vienna
– name: Springer Nature B.V
References Bird, Marur, Sniatynski, Greenberg, Kristal (CR8) 2011; 83
Hegyi (CR24) 2013; 8
Annamalai, Kosir, Tek (CR3) 2017; 8
Beninger, Beuk, Banasikowski, van Adel, Boivin, Reynolds (CR6) 2010; 21
Eggers (CR18) 2013; 80
Choi, Tarazi (CR14) 2010; 43
Lewis (CR35) 2012; 35
Shigeri, Shimamoto (CR51) 2006; 127
Rojo, Barbas, Ruperez (CR48) 2012; 4
Yang, Shi, Wang, Wang, He, Lu, Xu (CR60) 2010; 33
Samuelsson, Skogh, Lundberg, Vrethem, Ollinger (CR50) 2013; 210
Lee, Jayathilake, Dai, Meltzer (CR34) 2011; 185
Wharton, Morley, Isaacs, Cole, Lucas (CR57) 2004; 89
Danaceau, Chambers, Fountain (CR17) 2012; 4
Abboud, Noronha, Diwadkar (CR1) 2017; 44
Audhya, Adams, Johansen (CR4) 2012; 1820
Chen, Stanford, Mao, Abi-Dargham, Shungu, Lisanby, Schroeder, Kegeles (CR13) 2014; 4
CR47
Comasco, Vumma, Toffoletto, Johansson, Flyckt, Lewander, Oreland, Bjerkenstedt, Andreou, Soderman, Terenius, Agartz, Jonsson, Venizelos (CR15) 2016; 74
Xia, Broadhurst, Wilson, Wishart (CR58) 2013; 9
Jimenez, Ormazabal, Serrano, Ortez-Gonzalez, Artuch, Garcia-Cazorla, Campistol (CR28) 2012; 54
Li, Yin, Li, Kim, Wu (CR36) 2007; 98
Garcia-Canaveras, Donato, Castell, Lahoz (CR21) 2011; 10
Maeshima, Ohnuma, Sakai, Shibata, Baba, Ihara, Higashi, Ohkubo, Nozawa, Abe, Ichikawa, Nakano, Utsumi, Suzuki, Arai (CR39) 2007; 31
Thakkar, Rosler, Wijnen, Boer, Klomp, Cahn, Kahn, Neggers (CR56) 2017; 81
Koido, Innos, Haring, Zilmer, Ottas, Vasar (CR31) 2016; 10
Liubetskii, Selivestrov (CR37) 2005; 39
Yuan, Liu, Qiao, Sheng, Xu, Li, Chen (CR62) 2015; 2015
Galli (CR20) 2012; 42
Ota, Wakabayashi, Sato, Hori, Hattori, Teraishi, Ozawa, Okubo, Kunugi (CR46) 2015; 27
Iwasaki, Sawada, Hatayama, Ohyagi, Tsukuda, Namekawa, Ito, Saito, Nakazawa (CR27) 2012; 2
Takahashi, Kohno (CR53) 2016; 11
Koike, Bundo, Iwamoto, Suga, Kuwabara, Ohashi, Shinoda, Takano, Iwashiro, Satomura, Nagai, Natsubori, Tada, Yamasue, Kasai (CR32) 2014; 4
Cha, Kudlow, Baskaran, Mansur, McIntyre (CR12) 2014; 77
Tao, Lu, Xu, Zheng, Liu, Shen, Ruan (CR55) 2017; 2017
Anjum, Bathla, Panchal, Singh, Singh (CR2) 2017
Yao, Dougherty, Reddy, Keshavan, Montrose, Matson, Rozen, Krishnan, McEvoy, Kaddurah-Daouk (CR61) 2009; 15
Howes, Kapur (CR26) 2009; 35
Dahlberg, Ivanovic, Hassel (CR16) 2014; 69
Zhong, Cheng, Lu, Duan, Wang (CR63) 2016; 158
Olde Damink, Jalan, Redhead, Hayes, Deutz, Soeters (CR44) 2002; 36
Morshed, Sobhan, Nahar, Keramat Ali, Shams (CR42) 2005; 31
Bonnot, Klunemann, Sedel, Tordjman, Cohen, Walterfang (CR9) 2014; 9
Saleem, Shaukat, Gul, Arooj, Malik (CR49) 2017; 11
Macciardi, Lucca, Catalano, Marino, Zanardi, Smeraldi (CR38) 1990; 32
He, Yu, Giegling, Xie, Hartmann, Prehn, Adamski, Kahn, Li, Illig, Wang-Sattler, Rujescu (CR23) 2012; 2
Millier, Schmidt, Angermeyer, Chauhan, Murthy, Toumi, Cadi-Soussi (CR41) 2014; 54
Sinha, Giblen, AbdElgawad, De Rop, Asard, Blust, De Boeck (CR52) 2013; 130–131
Tanaka (CR54) 2008; 9
Eyjolfsson, Nilsen, Kondziella, Brenner, Haberg, Sonnewald (CR19) 2011; 31
Hoche, Klapperstuck, Wohlrab (CR25) 2004; 17
Jospeh, Baker, Crow, Riley, Risby (CR29) 1979; 62
Kegel, Bhat, Skogh, Samuelsson, Lundberg, Dahl, Sellgren, Schwieler, Engberg, Schuppe-Koistinen, Erhardt (CR30) 2014; 7
Murray, Lappin, Di Forti (CR43) 2008; 18
Cervenka, Agudelo, Ruas (CR11) 2017
Azizan, Ressom, Mendoza, Baharum (CR5) 2017; 5
Oresic, Tang, Seppanen-Laakso, Mattila, Saarni, Saarni, Lonnqvist, Sysi-Aho, Hyotylainen, Perala, Suvisaari (CR45) 2011; 3
Yablonsky-Alter, Agovic, Gashi, Lidsky, Friedman, Banerjee (CR59) 2009; 79
Cai, Zhu, Li, Zhang, Hu, Yang, Ye (CR10) 2010; 34
Larovere, Fairbanks, O’Neill, Arenas, Marinaki, Escuredo, de Kremer (CR33) 2012; 35
Gika, Theodoridis, Wilson (CR22) 2008; 31
Mikanmaa, Grent-’t-Jong, Lingling, Recasens, Thune, Uhlhaas (CR40) 2017
Bernstein, Bogerts, Keilhoff (CR7) 2005; 78
A Annamalai (2579_CR3) 2017; 8
I Cervenka (2579_CR11) 2017
E Mikanmaa (2579_CR40) 2017
JK Yao (2579_CR61) 2009; 15
DA Lewis (2579_CR35) 2012; 35
A Millier (2579_CR41) 2014; 54
D Rojo (2579_CR48) 2012; 4
S Saleem (2579_CR49) 2017; 11
OD Howes (2579_CR26) 2009; 35
K Takahashi (2579_CR53) 2016; 11
Q Yang (2579_CR60) 2010; 33
J Xia (2579_CR58) 2013; 9
E Yablonsky-Alter (2579_CR59) 2009; 79
AK Sinha (2579_CR52) 2013; 130–131
H Hegyi (2579_CR24) 2013; 8
P Li (2579_CR36) 2007; 98
F Galli (2579_CR20) 2012; 42
T Audhya (2579_CR4) 2012; 1820
Y He (2579_CR23) 2012; 2
F Hoche (2579_CR25) 2004; 17
KA Azizan (2579_CR5) 2017; 5
Y Iwasaki (2579_CR27) 2012; 2
M Samuelsson (2579_CR50) 2013; 210
KN Thakkar (2579_CR56) 2017; 81
E Comasco (2579_CR15) 2016; 74
Y Shigeri (2579_CR51) 2006; 127
YK Choi (2579_CR14) 2010; 43
L Yuan (2579_CR62) 2015; 2015
RM Murray (2579_CR43) 2008; 18
MH Jospeh (2579_CR29) 1979; 62
S Anjum (2579_CR2) 2017
AE Eggers (2579_CR18) 2013; 80
M Lee (2579_CR34) 2011; 185
R Abboud (2579_CR1) 2017; 44
HG Gika (2579_CR22) 2008; 31
JC Garcia-Canaveras (2579_CR21) 2011; 10
SS Bird (2579_CR8) 2011; 83
L Zhong (2579_CR63) 2016; 158
BA Wharton (2579_CR57) 2004; 89
S Koike (2579_CR32) 2014; 4
K Koido (2579_CR31) 2016; 10
D Dahlberg (2579_CR16) 2014; 69
O Bonnot (2579_CR9) 2014; 9
2579_CR47
HL Cai (2579_CR10) 2010; 34
F Tao (2579_CR55) 2017; 2017
NM Morshed (2579_CR42) 2005; 31
E Jimenez (2579_CR28) 2012; 54
H Maeshima (2579_CR39) 2007; 31
VA Liubetskii (2579_CR37) 2005; 39
M Oresic (2579_CR45) 2011; 3
DS Cha (2579_CR12) 2014; 77
SW Olde Damink (2579_CR44) 2002; 36
LE Larovere (2579_CR33) 2012; 35
CM Chen (2579_CR13) 2014; 4
RJ Beninger (2579_CR6) 2010; 21
HG Bernstein (2579_CR7) 2005; 78
EM Eyjolfsson (2579_CR19) 2011; 31
F Macciardi (2579_CR38) 1990; 32
S Tanaka (2579_CR54) 2008; 9
JP Danaceau (2579_CR17) 2012; 4
ME Kegel (2579_CR30) 2014; 7
M Ota (2579_CR46) 2015; 27
References_xml – volume: 4
  start-page: 1235
  issue: 10
  year: 2012
  end-page: 1243
  ident: CR48
  article-title: LC-MS metabolomics of polar compounds
  publication-title: Bioanalysis
  doi: 10.4155/bio.12.100
– volume: 5
  start-page: e3451
  year: 2017
  ident: CR5
  article-title: 13C based proteinogenic amino acid (PAA) and metabolic flux ratio analysis of reveals changes in pentose phosphate (PP) pathway in response to agitation and temperature related stresses
  publication-title: PeerJ
  doi: 10.7717/peerj.3451
– volume: 35
  start-page: 549
  issue: 3
  year: 2009
  end-page: 562
  ident: CR26
  article-title: The dopamine hypothesis of schizophrenia: version III—the final common pathway
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp006
– volume: 35
  start-page: S55
  year: 2012
  end-page: S55
  ident: CR33
  article-title: Genetic defects of purine and pyrimidine metabolism in Argentina (Period 1996-2012)
  publication-title: J Inherit Metab Dis
– volume: 54
  start-page: 85
  year: 2014
  end-page: 93
  ident: CR41
  article-title: Humanistic burden in schizophrenia: a literature review
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2014.03.021
– volume: 11
  start-page: e0150524
  issue: 3
  year: 2016
  ident: CR53
  article-title: Different polar metabolites and protein profiles between high- and low-quality Japanese Ginjo Sake
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0150524
– volume: 54
  start-page: 394
  issue: 7
  year: 2012
  end-page: 398
  ident: CR28
  article-title: Amino acids in cerebrospinal fluid and plasma: its usefulness in the study of neuropaediatric diseases
  publication-title: Rev Neurol
– volume: 9
  start-page: 41
  year: 2008
  ident: CR54
  article-title: Dysfunctional GABAergic inhibition in the prefrontal cortex leading to “psychotic” hyperactivation
  publication-title: BMC Neurosci
  doi: 10.1186/1471-2202-9-41
– volume: 31
  start-page: 15
  issue: 1
  year: 2005
  end-page: 20
  ident: CR42
  article-title: Excitatory aminoacid neurotransmitters in schizophrenia
  publication-title: Bangladesh Med Res Counc Bull
– volume: 127
  start-page: 279
  issue: 4
  year: 2006
  end-page: 287
  ident: CR51
  article-title: Pharmacology of inhibitory amino acid transporters (GABA transporters and glycine transporters)
  publication-title: Nihon Yakurigaku Zasshi
  doi: 10.1254/fpj.127.279
– volume: 8
  start-page: 390
  issue: 8
  year: 2017
  end-page: 396
  ident: CR3
  article-title: Prevalence of obesity and diabetes in patients with schizophrenia
  publication-title: World J Diabetes
  doi: 10.4239/wjd.v8.i8.390
– volume: 4
  start-page: 783
  issue: 7
  year: 2012
  end-page: 794
  ident: CR17
  article-title: Hydrophilic interaction chromatography (HILIC) for LC-MS/MS analysis of monoamine neurotransmitters
  publication-title: Bioanalysis
  doi: 10.4155/bio.12.46
– volume: 2017
  start-page: 7382752
  year: 2017
  ident: CR55
  article-title: Metabolomics analysis for defining serum biochemical markers in colorectal cancer patients with Qi deficiency syndrome or Yin deficiency syndrome
  publication-title: Evid Based Complement Altern Med
  doi: 10.1155/2017/7382752
– volume: 10
  start-page: 331
  year: 2016
  ident: CR31
  article-title: Taurine and epidermal growth factor belong to the signature of first-episode psychosis
  publication-title: Front Neurosci-Switz
– volume: 31
  start-page: 976
  issue: 3
  year: 2011
  end-page: 985
  ident: CR19
  article-title: Altered 13C glucose metabolism in the cortico-striato-thalamo-cortical loop in the MK-801 rat model of schizophrenia
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/jcbfm.2010.193
– volume: 18
  start-page: S129
  year: 2008
  end-page: S134
  ident: CR43
  article-title: Schizophrenia: from developmental deviance to dopamine dysregulation
  publication-title: Eur Neuropsychopharm
  doi: 10.1016/j.euroneuro.2008.04.002
– volume: 4
  start-page: e379
  year: 2014
  ident: CR32
  article-title: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2014.19
– volume: 9
  start-page: 65
  year: 2014
  ident: CR9
  article-title: Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/1750-1172-9-65
– volume: 34
  start-page: 1273
  issue: 7
  year: 2010
  end-page: 1278
  ident: CR10
  article-title: Elevated plasma gamma-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2010.07.006
– year: 2017
  ident: CR11
  article-title: Kynurenines: tryptophan’s metabolites in exercise, inflammation, and mental health
  publication-title: Science
  doi: 10.1126/science.aaf9794
– year: 2017
  ident: CR40
  article-title: Towards a neurodynamical understanding of the prodrome in schizophrenia
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2017.11.026
– volume: 69
  start-page: 41
  year: 2014
  end-page: 47
  ident: CR16
  article-title: High extracellular concentration of excitatory amino acids glutamate and aspartate in human brain abscess
  publication-title: Neurochem Int
  doi: 10.1016/j.neuint.2014.03.001
– volume: 21
  start-page: 1
  issue: 1
  year: 2010
  end-page: 10
  ident: CR6
  article-title: Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0b013e3283347091
– volume: 43
  start-page: 593
  issue: 9
  year: 2010
  end-page: 598
  ident: CR14
  article-title: Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr mice: relevance to schizophrenia
  publication-title: BMB Rep
  doi: 10.5483/BMBRep.2010.43.9.593
– volume: 62
  start-page: 279
  issue: 3
  year: 1979
  end-page: 285
  ident: CR29
  article-title: Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects
  publication-title: Psychopharmacology
  doi: 10.1007/BF00431959
– volume: 78
  start-page: 69
  issue: 1
  year: 2005
  end-page: 86
  ident: CR7
  article-title: The many faces of nitric oxide in schizophrenia. A review
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.05.019
– volume: 83
  start-page: 6648
  issue: 17
  year: 2011
  end-page: 6657
  ident: CR8
  article-title: Serum lipidomics profiling using LC-MS and high-energy collisional dissociation fragmentation: focus on triglyceride detection and characterization
  publication-title: Anal Chem
  doi: 10.1021/ac201195d
– volume: 158
  start-page: 351
  year: 2016
  end-page: 360
  ident: CR63
  article-title: Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations
  publication-title: Talanta
  doi: 10.1016/j.talanta.2016.04.049
– volume: 2015
  start-page: 506872
  year: 2015
  ident: CR62
  article-title: The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment
  publication-title: Biomed Res Int
  doi: 10.1155/2015/506872
– year: 2017
  ident: CR2
  article-title: Metabolic syndrome in drug naive schizophrenic patients
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2017.11.006
– ident: CR47
– volume: 31
  start-page: 1410
  issue: 7
  year: 2007
  end-page: 1418
  ident: CR39
  article-title: Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia—Juntendo University Schizophrenia Projects (JUSP)
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2007.06.009
– volume: 74
  start-page: 96
  issue: 2
  year: 2016
  end-page: 103
  ident: CR15
  article-title: Genetic and functional study of L-type amino acid transporter 1 in schizophrenia
  publication-title: Neuropsychobiology
  doi: 10.1159/000455234
– volume: 210
  start-page: 819
  issue: 3
  year: 2013
  end-page: 824
  ident: CR50
  article-title: Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2013.09.014
– volume: 44
  start-page: 125
  year: 2017
  end-page: 133
  ident: CR1
  article-title: Motor system dysfunction in the schizophrenia diathesis: neural systems to neurotransmitters
  publication-title: Eur Psychiatry
  doi: 10.1016/j.eurpsy.2017.04.004
– volume: 10
  start-page: 4825
  issue: 10
  year: 2011
  end-page: 4834
  ident: CR21
  article-title: A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations
  publication-title: J Proteome Res
  doi: 10.1021/pr200629p
– volume: 8
  start-page: 5
  year: 2013
  ident: CR24
  article-title: GABBR1 has a HERV-W LTR in its regulatory region–a possible implication for schizophrenia
  publication-title: Biol Direct
  doi: 10.1186/1745-6150-8-5
– volume: 17
  start-page: 283
  issue: 6
  year: 2004
  end-page: 288
  ident: CR25
  article-title: Effects of -ornithine on metabolic processes of the urea cycle in human keratinocytes
  publication-title: Skin Pharmacol Physiol
  doi: 10.1159/000081113
– volume: 3
  start-page: 19
  issue: 3
  year: 2011
  ident: CR45
  article-title: Metabolome in schizophrenia and other psychotic disorders: a general population-based study
  publication-title: Genome Med
  doi: 10.1186/gm233
– volume: 2
  start-page: 496
  issue: 3
  year: 2012
  end-page: 515
  ident: CR27
  article-title: Separation technique for the determination of highly polar metabolites in biological samples
  publication-title: Metabolites
  doi: 10.3390/metabo2030496
– volume: 98
  start-page: 237
  issue: 2
  year: 2007
  end-page: 252
  ident: CR36
  article-title: Amino acids and immune function
  publication-title: Br J Nutr
  doi: 10.1017/S000711450769936X
– volume: 79
  start-page: 215
  issue: 3–4
  year: 2009
  end-page: 218
  ident: CR59
  article-title: Cocaine challenge enhances release of neuroprotective amino acid taurine in the striatum of chronic cocaine treated rats: a microdialysis study
  publication-title: Brain Res Bull
  doi: 10.1016/j.brainresbull.2008.12.014
– volume: 15
  start-page: 938
  issue: 9
  year: 2009
  end-page: 953
  ident: CR61
  article-title: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2009.33
– volume: 80
  start-page: 791
  issue: 6
  year: 2013
  end-page: 794
  ident: CR18
  article-title: A serotonin hypothesis of schizophrenia
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2013.03.013
– volume: 7
  start-page: 15
  year: 2014
  end-page: 22
  ident: CR30
  article-title: Imbalanced kynurenine pathway in schizophrenia
  publication-title: Int J Tryptophan Res
  doi: 10.4137/IJTR.S16800
– volume: 32
  start-page: 63
  issue: 1
  year: 1990
  end-page: 70
  ident: CR38
  article-title: Amino acid patterns in schizophrenia: some new findings
  publication-title: Psychiatry Res
  doi: 10.1016/0165-1781(90)90136-S
– volume: 27
  start-page: 291
  issue: 5
  year: 2015
  end-page: 296
  ident: CR46
  article-title: Effect of L-theanine on glutamatergic function in patients with schizophrenia
  publication-title: Acta Neuropsychiatr
  doi: 10.1017/neu.2015.22
– volume: 81
  start-page: 525
  issue: 6
  year: 2017
  end-page: 535
  ident: CR56
  article-title: 7T proton magnetic resonance spectroscopy of gamma-aminobutyric acid, glutamate, and glutamine reveals altered concentrations in patients with schizophrenia and healthy siblings
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2016.04.007
– volume: 89
  start-page: F497
  issue: 6
  year: 2004
  end-page: F498
  ident: CR57
  article-title: Low plasma taurine and later neurodevelopment
  publication-title: Arch Dis Child Fetal Neonatal Ed
  doi: 10.1136/adc.2003.048389
– volume: 9
  start-page: 280
  issue: 2
  year: 2013
  end-page: 299
  ident: CR58
  article-title: Translational biomarker discovery in clinical metabolomics: an introductory tutorial
  publication-title: Metabolomics
  doi: 10.1007/s11306-012-0482-9
– volume: 35
  start-page: 1871
  issue: 12
  year: 2012
  end-page: 1878
  ident: CR35
  article-title: Cortical circuit dysfunction and cognitive deficits in schizophrenia–implications for preemptive interventions
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2012.08156.x
– volume: 1820
  start-page: 1496
  issue: 10
  year: 2012
  end-page: 1501
  ident: CR4
  article-title: Correlation of serotonin levels in CSF, platelets, plasma, and urine
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2012.05.012
– volume: 39
  start-page: 1072
  issue: 6
  year: 2005
  end-page: 1075
  ident: CR37
  article-title: Gene expression regulation for amino acid biosynthesis and aminoacyl-tRNA synthetases in actinobacteria
  publication-title: Mol Biol (Mosk)
– volume: 31
  start-page: 1598
  issue: 9
  year: 2008
  end-page: 1608
  ident: CR22
  article-title: Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine
  publication-title: J Sep Sci
  doi: 10.1002/jssc.200700644
– volume: 77
  start-page: 481
  year: 2014
  end-page: 486
  ident: CR12
  article-title: Implications of epigenetic modulation for novel treatment approaches in patients with schizophrenia
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2013.08.038
– volume: 33
  start-page: 1495
  issue: 10
  year: 2010
  end-page: 1503
  ident: CR60
  article-title: Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system
  publication-title: J Sep Sci
  doi: 10.1002/jssc.200900798
– volume: 11
  start-page: 63
  issue: 3
  year: 2017
  end-page: 68
  ident: CR49
  article-title: Potential role of amino acids in pathogenesis of schizophrenia
  publication-title: Int J Health Sci (Qassim)
– volume: 2
  start-page: e149
  year: 2012
  ident: CR23
  article-title: Schizophrenia shows a unique metabolomics signature in plasma
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.76
– volume: 36
  start-page: 1163
  issue: 5
  year: 2002
  end-page: 1171
  ident: CR44
  article-title: Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS
  publication-title: Hepatology
  doi: 10.1053/jhep.2002.36497
– volume: 4
  start-page: 531
  year: 2014
  end-page: 539
  ident: CR13
  article-title: GABA level, gamma oscillation, and working memory performance in schizophrenia
  publication-title: Neuroimage Clin
  doi: 10.1016/j.nicl.2014.03.007
– volume: 42
  start-page: 1
  issue: 1
  year: 2012
  end-page: 4
  ident: CR20
  article-title: Amino acid and protein modification by oxygen and nitrogen species
  publication-title: Amino Acids
  doi: 10.1007/s00726-010-0670-8
– volume: 130–131
  start-page: 86
  year: 2013
  end-page: 96
  ident: CR52
  article-title: Regulation of amino acid metabolism as a defensive strategy in the brain of three freshwater teleosts in response to high environmental ammonia exposure
  publication-title: Aquat Toxicol
  doi: 10.1016/j.aquatox.2013.01.003
– volume: 185
  start-page: 328
  issue: 3
  year: 2011
  end-page: 333
  ident: CR34
  article-title: Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2010.07.013
– volume: 3
  start-page: 19
  issue: 3
  year: 2011
  ident: 2579_CR45
  publication-title: Genome Med
  doi: 10.1186/gm233
– volume: 4
  start-page: 1235
  issue: 10
  year: 2012
  ident: 2579_CR48
  publication-title: Bioanalysis
  doi: 10.4155/bio.12.100
– volume: 8
  start-page: 5
  year: 2013
  ident: 2579_CR24
  publication-title: Biol Direct
  doi: 10.1186/1745-6150-8-5
– volume: 83
  start-page: 6648
  issue: 17
  year: 2011
  ident: 2579_CR8
  publication-title: Anal Chem
  doi: 10.1021/ac201195d
– volume: 77
  start-page: 481
  year: 2014
  ident: 2579_CR12
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2013.08.038
– volume: 2
  start-page: e149
  year: 2012
  ident: 2579_CR23
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.76
– volume: 36
  start-page: 1163
  issue: 5
  year: 2002
  ident: 2579_CR44
  publication-title: Hepatology
  doi: 10.1053/jhep.2002.36497
– volume: 5
  start-page: e3451
  year: 2017
  ident: 2579_CR5
  publication-title: PeerJ
  doi: 10.7717/peerj.3451
– year: 2017
  ident: 2579_CR11
  publication-title: Science
  doi: 10.1126/science.aaf9794
– volume: 89
  start-page: F497
  issue: 6
  year: 2004
  ident: 2579_CR57
  publication-title: Arch Dis Child Fetal Neonatal Ed
  doi: 10.1136/adc.2003.048389
– volume: 130–131
  start-page: 86
  year: 2013
  ident: 2579_CR52
  publication-title: Aquat Toxicol
  doi: 10.1016/j.aquatox.2013.01.003
– volume: 15
  start-page: 938
  issue: 9
  year: 2009
  ident: 2579_CR61
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2009.33
– volume: 10
  start-page: 331
  year: 2016
  ident: 2579_CR31
  publication-title: Front Neurosci-Switz
– volume: 27
  start-page: 291
  issue: 5
  year: 2015
  ident: 2579_CR46
  publication-title: Acta Neuropsychiatr
  doi: 10.1017/neu.2015.22
– ident: 2579_CR47
  doi: 10.1038/sj.mp.4001511
– volume: 35
  start-page: 549
  issue: 3
  year: 2009
  ident: 2579_CR26
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp006
– volume: 18
  start-page: S129
  year: 2008
  ident: 2579_CR43
  publication-title: Eur Neuropsychopharm
  doi: 10.1016/j.euroneuro.2008.04.002
– volume: 35
  start-page: 1871
  issue: 12
  year: 2012
  ident: 2579_CR35
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2012.08156.x
– volume: 74
  start-page: 96
  issue: 2
  year: 2016
  ident: 2579_CR15
  publication-title: Neuropsychobiology
  doi: 10.1159/000455234
– volume: 35
  start-page: S55
  year: 2012
  ident: 2579_CR33
  publication-title: J Inherit Metab Dis
– volume: 69
  start-page: 41
  year: 2014
  ident: 2579_CR16
  publication-title: Neurochem Int
  doi: 10.1016/j.neuint.2014.03.001
– volume: 78
  start-page: 69
  issue: 1
  year: 2005
  ident: 2579_CR7
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.05.019
– volume: 10
  start-page: 4825
  issue: 10
  year: 2011
  ident: 2579_CR21
  publication-title: J Proteome Res
  doi: 10.1021/pr200629p
– year: 2017
  ident: 2579_CR2
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2017.11.006
– volume: 127
  start-page: 279
  issue: 4
  year: 2006
  ident: 2579_CR51
  publication-title: Nihon Yakurigaku Zasshi
  doi: 10.1254/fpj.127.279
– volume: 98
  start-page: 237
  issue: 2
  year: 2007
  ident: 2579_CR36
  publication-title: Br J Nutr
  doi: 10.1017/S000711450769936X
– volume: 21
  start-page: 1
  issue: 1
  year: 2010
  ident: 2579_CR6
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0b013e3283347091
– volume: 32
  start-page: 63
  issue: 1
  year: 1990
  ident: 2579_CR38
  publication-title: Psychiatry Res
  doi: 10.1016/0165-1781(90)90136-S
– volume: 43
  start-page: 593
  issue: 9
  year: 2010
  ident: 2579_CR14
  publication-title: BMB Rep
  doi: 10.5483/BMBRep.2010.43.9.593
– volume: 17
  start-page: 283
  issue: 6
  year: 2004
  ident: 2579_CR25
  publication-title: Skin Pharmacol Physiol
  doi: 10.1159/000081113
– volume: 4
  start-page: 531
  year: 2014
  ident: 2579_CR13
  publication-title: Neuroimage Clin
  doi: 10.1016/j.nicl.2014.03.007
– volume: 34
  start-page: 1273
  issue: 7
  year: 2010
  ident: 2579_CR10
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2010.07.006
– year: 2017
  ident: 2579_CR40
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2017.11.026
– volume: 11
  start-page: e0150524
  issue: 3
  year: 2016
  ident: 2579_CR53
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0150524
– volume: 11
  start-page: 63
  issue: 3
  year: 2017
  ident: 2579_CR49
  publication-title: Int J Health Sci (Qassim)
– volume: 79
  start-page: 215
  issue: 3–4
  year: 2009
  ident: 2579_CR59
  publication-title: Brain Res Bull
  doi: 10.1016/j.brainresbull.2008.12.014
– volume: 2017
  start-page: 7382752
  year: 2017
  ident: 2579_CR55
  publication-title: Evid Based Complement Altern Med
  doi: 10.1155/2017/7382752
– volume: 9
  start-page: 280
  issue: 2
  year: 2013
  ident: 2579_CR58
  publication-title: Metabolomics
  doi: 10.1007/s11306-012-0482-9
– volume: 4
  start-page: 783
  issue: 7
  year: 2012
  ident: 2579_CR17
  publication-title: Bioanalysis
  doi: 10.4155/bio.12.46
– volume: 2
  start-page: 496
  issue: 3
  year: 2012
  ident: 2579_CR27
  publication-title: Metabolites
  doi: 10.3390/metabo2030496
– volume: 62
  start-page: 279
  issue: 3
  year: 1979
  ident: 2579_CR29
  publication-title: Psychopharmacology
  doi: 10.1007/BF00431959
– volume: 33
  start-page: 1495
  issue: 10
  year: 2010
  ident: 2579_CR60
  publication-title: J Sep Sci
  doi: 10.1002/jssc.200900798
– volume: 1820
  start-page: 1496
  issue: 10
  year: 2012
  ident: 2579_CR4
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagen.2012.05.012
– volume: 80
  start-page: 791
  issue: 6
  year: 2013
  ident: 2579_CR18
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2013.03.013
– volume: 54
  start-page: 85
  year: 2014
  ident: 2579_CR41
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2014.03.021
– volume: 9
  start-page: 41
  year: 2008
  ident: 2579_CR54
  publication-title: BMC Neurosci
  doi: 10.1186/1471-2202-9-41
– volume: 31
  start-page: 976
  issue: 3
  year: 2011
  ident: 2579_CR19
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/jcbfm.2010.193
– volume: 81
  start-page: 525
  issue: 6
  year: 2017
  ident: 2579_CR56
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2016.04.007
– volume: 31
  start-page: 1410
  issue: 7
  year: 2007
  ident: 2579_CR39
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2007.06.009
– volume: 8
  start-page: 390
  issue: 8
  year: 2017
  ident: 2579_CR3
  publication-title: World J Diabetes
  doi: 10.4239/wjd.v8.i8.390
– volume: 9
  start-page: 65
  year: 2014
  ident: 2579_CR9
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/1750-1172-9-65
– volume: 7
  start-page: 15
  year: 2014
  ident: 2579_CR30
  publication-title: Int J Tryptophan Res
  doi: 10.4137/IJTR.S16800
– volume: 2015
  start-page: 506872
  year: 2015
  ident: 2579_CR62
  publication-title: Biomed Res Int
  doi: 10.1155/2015/506872
– volume: 44
  start-page: 125
  year: 2017
  ident: 2579_CR1
  publication-title: Eur Psychiatry
  doi: 10.1016/j.eurpsy.2017.04.004
– volume: 31
  start-page: 15
  issue: 1
  year: 2005
  ident: 2579_CR42
  publication-title: Bangladesh Med Res Counc Bull
– volume: 158
  start-page: 351
  year: 2016
  ident: 2579_CR63
  publication-title: Talanta
  doi: 10.1016/j.talanta.2016.04.049
– volume: 31
  start-page: 1598
  issue: 9
  year: 2008
  ident: 2579_CR22
  publication-title: J Sep Sci
  doi: 10.1002/jssc.200700644
– volume: 54
  start-page: 394
  issue: 7
  year: 2012
  ident: 2579_CR28
  publication-title: Rev Neurol
  doi: 10.33588/rn.5407.2011454
– volume: 42
  start-page: 1
  issue: 1
  year: 2012
  ident: 2579_CR20
  publication-title: Amino Acids
  doi: 10.1007/s00726-010-0670-8
– volume: 39
  start-page: 1072
  issue: 6
  year: 2005
  ident: 2579_CR37
  publication-title: Mol Biol (Mosk)
– volume: 185
  start-page: 328
  issue: 3
  year: 2011
  ident: 2579_CR34
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2010.07.013
– volume: 210
  start-page: 819
  issue: 3
  year: 2013
  ident: 2579_CR50
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2013.09.014
– volume: 4
  start-page: e379
  year: 2014
  ident: 2579_CR32
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2014.19
SSID ssj0012816
Score 2.397651
Snippet Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1013
SubjectTerms Adolescent
Adult
Age
Aged
Amino acids
Amino Acids - blood
Ammonia
Analytical Chemistry
Arginine
aspartic acid
Biochemical Engineering
Biochemistry
Biological Variation, Individual
Biomedical and Life Sciences
Biosynthesis
Body mass index
Body size
Case-Control Studies
Chromatography
cysteine
Derivatives
Diagnostic systems
Female
gamma-aminobutyric acid
Generalized linear models
Glutamine
Humans
hydrophilic interaction chromatography
kynurenine
Life Sciences
linear models
Liquid chromatography
Male
Mass spectrometry
Mass spectroscopy
Mental disorders
Metabolism
Middle Aged
Neurobiology
Neurotransmission
Neurotransmitters
Original Article
Ornithine
Pathophysiology
Proteomics
Sarcosine
sarcosines
Schizophrenia
Schizophrenia - blood
Sex
Statistical analysis
Statistical methods
Statistical models
tandem mass spectrometry
Taurine
Threonine
Tryptophan
Urea
urea cycle
Young Adult
γ-Aminobutyric acid
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NatwwEB6a9JBcStomrZu0KNBTi8D6sbXqbVm6hEJ76sLejH5hIfWWenPpqe-QN8yTVKO1nYSkC70ZJAt7Zqz55Jn5BuC90K5KOJ7RGL2g0jhDdTkJVCdw4FiMZQhYnPz1W32xkF-W1bKv4-6GbPchJJl36rHYDUmu8fSbNFspTes9eFrh0T0Z8YJPx9ABn-R-p-mkrimybw2hzMeWuO-MHiDMB9HR7HTmR_CsR4tkulXvc3gS2hdwMBuatL2EOBsJl3-nFYj5sWrX1LiVJ3a1xuSMTNzZkdxUqNuQ1ViA1RH8B0u6u1l3n4ghLvm1mz_XfQ47yfyzx7CYf_4-u6B96wTqpBAb6gXz3kchy-iYMJGrSSWltiGWzNp0XdpaO66NqpWP3jrFnLfRWYQfMTBxAvvtug2vgUy0wiae3CsWZDq26qAwybryWjLJDCugHGTYuJ5XHNtbXDYjI3IWe5PE3qDYm7qAD-MtP7ekGrsmnw2Kafrvq2s4-lGZoBV_dDjtK5VKSEvIAs7H4aQajIaYNqyv8hIVktsrtWMOw1AU1qUV8GprE-MDc610ncBlAR8HI7l9gH--zZv_mn0KhxytNSccnsH-5tdVeJtA0Ma-y0b_F1kd_3g
  priority: 102
  providerName: Springer Nature
Title Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study
URI https://link.springer.com/article/10.1007/s00726-018-2579-6
https://www.ncbi.nlm.nih.gov/pubmed/29796929
https://www.proquest.com/docview/2042949372
https://www.proquest.com/docview/3195739734
https://www.proquest.com/docview/2045275077
https://www.proquest.com/docview/2101328335
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5Be4AL4k2gVEbiBLKIH4nXXNCy2m0FokKIlZZT5PghrQRJ22wvnPgP_EN-CR5vkoIKe0mi2LGc8SQz9jf-BuC50LaIfjyjIThBpbGG6nziqY7OgWUh5N7j5uQPJ-XxUr5bFat-wa3rwyqHf2L6UbvW4hr5q6gqhYrGU8g3p2cUs0Yhutqn0LgO-0hdhiFdajVOuBAkSlilRrRTFmxANfNEIqo4zqWjnhRK0_Jvu3TF2bwClCb7s7gNt3rHkUy3I30HrvnmLtyYDfna7kGYjdzL32MLxHxbNy01du1IvW4xTiNxeHYk5RfqNmQ97sXqCC7Hku7PALzXxBAbTdyvHz_7cHaSqGjvw3Ix_zw7pn0WBWqlEBvqBHPOBSHzYJkwgatJIaWufchZXcfrvC615dqoUrngaquYdXWwNXoiwTPxAPaatvGPgEy0wnye3CnmZZzBaq8w3rpwWjLJDMsgH2RY2Z5iHDNdfK1GcuQk9iqKvUKxV2UGL8ZHTrf8GrsqHwwDU_WfWldxNKkyeln8n8WXepPBs7E4Dg0CI6bx7UVqokCee6V21GGISuEWtQwebnVi7DDXSpfRz8zg5aAklx3479s83t3dJ3CTo3qmYMMD2NucX_in0QHa1IdJy-Nxsjg6hP3p0Zf383h-Oz_5-CneXfLpb6ntCAE
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFL0qZVE2iDcpBYwEG5BF_EgcIyGEBoYpfaxaqbuQ-CGNBElLpkKw4h_4Dz6KL8HXk6Sgwuy6i-TEcq6Pfa99HwfgsdAmC3Y8o95bQWVlKqrTwlEdjAPDvE-dw-Tkvf18dijfH2VHa_BzyIXBsMphT4wbtW0N3pE_D1DJVFCeQr46PqHIGoXe1YFCYwmLHff1SziydS-334T5fcL59O3BZEZ7VgFqpBALagWz1nohU2-YqDxXRSalrp1PWV2H57TOteG6Urmy3tZGMWNrb2rUzN4xEfq9BJdDXxpXVDF9N3oteBGpVlON3lWZscGLmsaipYrj2T3gMlOa5n_rwXPG7TnHbNR302twtTdUyeslsq7DmmtuwMZk4Ie7CX4y1nr-Fnog1ad509LKzC2p5y3GhcSaoR2JfEbdgszH3K-O4PUv6f4M-HtBKmKCSv31_UcfPk9i6dtbcHgh8r0N603buLtACq2QP5RbxZwMJ2btFMZ3Z1ZLJlnFEkgHGZamL2mOzBofy7EYcxR7GcReotjLPIGn4yfHy3oeq17eGiam7Jd2V3JU4TJYdfyfzWc4TeDR2BymBh0xVePa09hFhnX1lVrxDkMvGKbEJXBniYlxwFwrnQe7NoFnA0jOBvDfv9lcPdyHsDE72Nstd7f3d-7BFY5QjYGOW7C--Hzq7gfja1E_iIgn8OGil9hvzP5B3A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIkEvFc-SUsBIcAFZjR-J10gIoS2rlkLFgUp7C4kf0ko0KWSrqpz4D_wbfg6_BI83SUGFvfUWyYnljL_xzHheAE-ENlnQ4xn13goqS1NSnY4c1UE5MMz71DlMTn5_kO8eyrfTbLoCP_tcGAyr7M_EeFDbxuAd-XaASqaC8BRy23dhER92Jq-Ov1DsIIWe1r6dxgIi--7sNJhv7cu9nbDXTzmfvPk43qVdhwFqpBBzagWz1nohU2-YKD1Xo0xKXTmfsqoKz2mVa8N1qXJlva2MYsZW3lQopb1jIsx7Ba4qkTHkMTUdjD10UEU_qUZPq8xY71FNYwFTxdGODxjNlKb53zLxgqJ7wUkbZd_kBqx3Sit5vUDZTVhx9S24Pu57xd0GPx7qPn8LM5DyaFY3tDQzS6pZgzEisX5oS2Jvo3ZOZkMeWEvwKpi0fwb_vSAlMUG8_vr-owulJ7EM7h04vBT63oXVuqndPSAjrbCXKLeKORmsZ-0UxnpnVksmWckSSHsaFqYrb45dNj4XQ2HmSPYikL1Ashd5As-GT44XtT2WvbzVb0zRsXlbcBTnMmh4_J_D55hN4PEwHLYGnTJl7ZqTOEWGNfaVWvIOQ48YpsclsLHAxLBgrpXOg46bwPMeJOcL-O_fbC5f7iO4FpireLd3sH8f1jgiNcY8bsHq_OuJexD0sHn1MAKewKfL5rDfmjBGCQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterizing+amino-acid+biosignatures+amongst+individuals+with+schizophrenia%3A+a+case%E2%80%93control+study&rft.jtitle=Amino+acids&rft.date=2018-08-01&rft.pub=Springer+Nature+B.V&rft.issn=0939-4451&rft.eissn=1438-2199&rft.volume=50&rft.issue=8&rft.spage=1013&rft.epage=1023&rft_id=info:doi/10.1007%2Fs00726-018-2579-6&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-4451&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-4451&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-4451&client=summon